annual cash & cash equivalents:
$163.77M-$77.05M(-32.00%)Summary
- As of today (September 18, 2025), NVCR annual cash & cash equivalents is $163.77 million, with the most recent change of -$77.05 million (-32.00%) on December 31, 2024.
- During the last 3 years, NVCR annual cash & cash equivalents has fallen by -$45.03 million (-21.57%).
- NVCR annual cash & cash equivalents is now -32.00% below its all-time high of $240.82 million, reached on December 31, 2023.
Performance
NVCR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$914.03M-$17.25M(-1.85%)Summary
- As of today (September 18, 2025), NVCR quarterly cash & cash equivalents is $914.03 million, with the most recent change of -$17.25 million (-1.85%) on June 30, 2025.
- Over the past year, NVCR quarterly cash & cash equivalents has dropped by -$40.80 million (-4.27%).
- NVCR quarterly cash & cash equivalents is now -5.82% below its all-time high of $970.55 million, reached on September 30, 2022.
Performance
NVCR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NVCR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.0% | -4.3% |
| 3 y3 years | -21.6% | -3.7% |
| 5 y5 years | -7.6% | +163.0% |
NVCR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | +42.0% | -5.8% | +4.6% |
| 5 y | 5-year | -32.0% | +42.0% | -5.8% | +288.3% |
| alltime | all time | -32.0% | +184.3% | -5.8% | +1486.5% |
NVCR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $914.03M(-1.9%) |
| Mar 2025 | - | $931.28M(-3.2%) |
| Dec 2024 | $163.77M(-32.0%) | $962.20M(-0.2%) |
| Sep 2024 | - | $963.67M(+0.9%) |
| Jun 2024 | - | $954.83M(+9.3%) |
| Mar 2024 | - | $873.75M(-4.2%) |
| Dec 2023 | $240.82M(+108.8%) | $912.36M(-1.1%) |
| Sep 2023 | - | $922.90M(-2.0%) |
| Jun 2023 | - | $941.33M(-1.8%) |
| Mar 2023 | - | $958.71M(-1.2%) |
| Dec 2022 | $115.33M(-44.8%) | $969.93M(-0.1%) |
| Sep 2022 | - | $970.55M(+2.2%) |
| Jun 2022 | - | $949.27M(+1.7%) |
| Mar 2022 | - | $933.19M(-0.6%) |
| Dec 2021 | $208.80M(-11.0%) | $938.51M(+0.4%) |
| Sep 2021 | - | $934.64M(+2.7%) |
| Jun 2021 | - | $910.49M(+4.0%) |
| Mar 2021 | - | $875.83M(+2.5%) |
| Dec 2020 | $234.67M(+32.3%) | $854.08M(+262.8%) |
| Sep 2020 | - | $235.38M(-32.3%) |
| Jun 2020 | - | $347.51M(+4.7%) |
| Mar 2020 | - | $332.05M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $177.32M(+26.1%) | $328.19M(+4.3%) |
| Sep 2019 | - | $314.73M(+9.8%) |
| Jun 2019 | - | $286.69M(+10.8%) |
| Mar 2019 | - | $258.70M(+4.3%) |
| Dec 2018 | $140.62M(+78.9%) | $248.01M(+7.9%) |
| Sep 2018 | - | $229.90M(+4.0%) |
| Jun 2018 | - | $221.12M(+1.2%) |
| Mar 2018 | - | $218.47M(+17.8%) |
| Dec 2017 | $78.59M(-21.2%) | $185.44M(-1.7%) |
| Sep 2017 | - | $188.69M(+1.5%) |
| Jun 2017 | - | $185.91M(-2.6%) |
| Mar 2017 | - | $190.79M(-13.2%) |
| Dec 2016 | $99.78M(-16.4%) | $219.90M(-6.7%) |
| Sep 2016 | - | $235.62M(+17.3%) |
| Jun 2016 | - | $200.95M(-14.8%) |
| Mar 2016 | - | $235.86M(-12.5%) |
| Dec 2015 | $119.42M(+107.3%) | $269.51M(+96.0%) |
| Sep 2015 | - | $137.49M(-16.0%) |
| Jun 2015 | - | $163.60M(+69.8%) |
| Mar 2015 | - | $96.35M(+67.2%) |
| Dec 2014 | $57.61M(-67.2%) | $57.61M |
| Dec 2013 | $175.89M | - |
FAQ
- What is NovoCure Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NovoCure Limited?
- What is NovoCure Limited annual cash & cash equivalents year-on-year change?
- What is NovoCure Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for NovoCure Limited?
- What is NovoCure Limited quarterly cash & cash equivalents year-on-year change?
What is NovoCure Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of NVCR is $163.77M
What is the all time high annual cash & cash equivalents for NovoCure Limited?
NovoCure Limited all-time high annual cash & cash equivalents is $240.82M
What is NovoCure Limited annual cash & cash equivalents year-on-year change?
Over the past year, NVCR annual cash & cash equivalents has changed by -$77.05M (-32.00%)
What is NovoCure Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of NVCR is $914.03M
What is the all time high quarterly cash & cash equivalents for NovoCure Limited?
NovoCure Limited all-time high quarterly cash & cash equivalents is $970.55M
What is NovoCure Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, NVCR quarterly cash & cash equivalents has changed by -$40.80M (-4.27%)